"The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies"
GLR3.3 is required for GSH-triggered systemic [Ca 2+ ] cyt propagation GLR proteins which generally contain an amino-terminal domain (ATD), a ligand-binding domain (LBD), a transmembrane domain (TMD), and a carboxyl-terminal domain (CTD), have broad agonist profiles including glycine, cysteine, methionine, Glu and GSH 29,30,31,32
This concept of pulsatility remains highly relevant within peptide science
10.1016/j.bbi.2009.08.001 51 FajaS.DawsonG
The next wave dual and triple agonists (GLP-1 + GIP + glucagon: tirzepatide, retatrutide, survodutide) are showing superior fat loss, better hepatic outcomes, and potentially preserved lean mass